Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 190

1.

Bile duct adenoma should not be designated as a reactive process.

Pujals A, Zafrani ES, Calderaro J.

Pathol Int. 2015 Mar 2. doi: 10.1111/pin.12273. [Epub ahead of print] No abstract available.

PMID:
25727261
[PubMed - as supplied by publisher]
2.

BRAF V600E Mutational Status in Bile Duct Adenomas and Hamartomas.

Pujals A, Bioulac-Sage P, Castain C, Charpy C, Zafrani ES, Calderaro J.

Histopathology. 2015 Feb 19. doi: 10.1111/his.12674. [Epub ahead of print]

PMID:
25704541
[PubMed - as supplied by publisher]
3.

Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.

Nault JC, Calderaro J, Di Tommaso L, Balabaud C, Zafrani ES, Bioulac-Sage P, Roncalli M, Zucman-Rossi J.

Hepatology. 2014 Dec;60(6):1983-92. doi: 10.1002/hep.27372. Epub 2014 Oct 27.

PMID:
25123086
[PubMed - indexed for MEDLINE]
4.

Primary biliary cirrhosis: proposal for a new simple histological scoring system.

Wendum D, Boëlle PY, Bedossa P, Zafrani ES, Charlotte F, Saint-Paul MC, Michalak S, Chazouillères O, Corpechot C.

Liver Int. 2015 Feb;35(2):652-9. doi: 10.1111/liv.12620. Epub 2014 Jul 8.

PMID:
24939754
[PubMed - in process]
5.

BRAF V600E mutations in bile duct adenomas.

Pujals A, Amaddeo G, Castain C, Bioulac-Sage P, Compagnon P, Zucman-Rossi J, Azoulay D, Leroy K, Zafrani ES, Calderaro J.

Hepatology. 2015 Jan;61(1):403-5. doi: 10.1002/hep.27133. Epub 2014 May 19. No abstract available.

PMID:
24634053
[PubMed - in process]
6.

Hepatocellular carcinoma and nodular regenerative hyperplasia after chemotherapy for metastatic colorectal carcinoma.

Calderaro J, Azoulay D, Zafrani ES.

Hepatology. 2014 Oct;60(4):1440-1. doi: 10.1002/hep.27115. Epub 2014 Apr 29. No abstract available.

PMID:
24604623
[PubMed - in process]
7.

Improved fibrosis staging by elastometry and blood test in chronic hepatitis C.

Calès P, Boursier J, Ducancelle A, Oberti F, Hubert I, Hunault G, de Lédinghen V, Zarski JP, Salmon D, Lunel F; ANRS HC EP 23 Fibrostar Study.

Liver Int. 2014 Jul;34(6):907-17. doi: 10.1111/liv.12327. Epub 2013 Oct 16.

PMID:
24102852
[PubMed - indexed for MEDLINE]
8.

AST/ALT ratio is not an index of liver fibrosis in chronic hepatitis C when aminotransferase activities are determinate according to the international recommendations.

Guéchot J, Boisson RC, Zarski JP, Sturm N, Calès P, Lasnier E; ANRS HCEP 23 Fibrostar Group.

Clin Res Hepatol Gastroenterol. 2013 Nov;37(5):467-72. doi: 10.1016/j.clinre.2013.07.003. Epub 2013 Aug 8.

PMID:
23932706
[PubMed - indexed for MEDLINE]
9.

Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver.

Guillot A, Hamdaoui N, Bizy A, Zoltani K, Souktani R, Zafrani ES, Mallat A, Lotersztajn S, Lafdil F.

Hepatology. 2014 Jan;59(1):296-306. doi: 10.1002/hep.26598. Epub 2013 Nov 19.

PMID:
23813495
[PubMed - indexed for MEDLINE]
10.

Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C.

Boursier J, de Ledinghen V, Sturm N, Amrani L, Bacq Y, Sandrini J, Le Bail B, Chaigneau J, Zarski JP, Gallois Y, Leroy V, Al Hamany Z, Oberti F, Fouchard-Hubert I, Dib N, Bertrais S, Rousselet MC, Calès P; Multicentre group ANRS HC EP23 FIBROSTAR.

J Gastroenterol. 2014 Mar;49(3):527-37. doi: 10.1007/s00535-013-0819-9. Epub 2013 May 17.

PMID:
23681425
[PubMed - indexed for MEDLINE]
11.

Contribution of the ELFG test in algorithms of non-invasive markers towards the diagnosis of significant fibrosis in chronic hepatitis C.

Zarski JP, Sturm N, Guechot J, Zafrani ES, Vaubourdolle M, Thoret S, Margier J, David-Tchouda S, Bosson JL.

PLoS One. 2013;8(3):e59088. doi: 10.1371/journal.pone.0059088. Epub 2013 Mar 21.

PMID:
23555619
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Non-invasive assessment of liver graft fibrosis by transient elastography after liver transplantation.

Barrault C, Roudot-Thoraval F, Tran Van Nhieu J, Atanasiu C, Kluger MD, Medkour F, Douvin C, Mallat A, Zafrani ES, Cherqui D, Duvoux C.

Clin Res Hepatol Gastroenterol. 2013 Sep;37(4):347-52. doi: 10.1016/j.clinre.2012.11.003. Epub 2013 Jan 11.

PMID:
23318116
[PubMed - indexed for MEDLINE]
13.

Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy.

Bosselut N, Taibi L, Guéchot J, Zarski JP, Sturm N, Gelineau MC, Poggi B, Thoret S, Lasnier E, Baudin B, Housset C, Vaubourdolle M; ANRS HCEP 23 Fibrostar Group.

Clin Chim Acta. 2013 Jan 16;415:63-8. doi: 10.1016/j.cca.2012.09.020. Epub 2012 Sep 27.

PMID:
23022619
[PubMed - indexed for MEDLINE]
14.

Neutrophilic cholangitis in psoriasis vulgaris and psoriatic arthritis.

Dieude P, Sbidian E, Viguier M, Zafrani E, de Bazelaire C, Dawidowicz K, Adle-Biassette H, Allez M, Petit A, Richette P, Bachelez H.

Br J Dermatol. 2013 Jan;168(1):216-8. doi: 10.1111/j.1365-2133.2012.11157.x. Epub 2012 Sep 13. No abstract available.

PMID:
22971251
[PubMed - indexed for MEDLINE]
15.

Determination of reliability criteria for liver stiffness evaluation by transient elastography.

Boursier J, Zarski JP, de Ledinghen V, Rousselet MC, Sturm N, Lebail B, Fouchard-Hubert I, Gallois Y, Oberti F, Bertrais S, Calès P; Multicentric Group from ANRS/HC/EP23 FIBROSTAR Studies.

Hepatology. 2013 Mar;57(3):1182-91. doi: 10.1002/hep.25993. Epub 2013 Feb 4.

PMID:
22899556
[PubMed - indexed for MEDLINE]
16.

Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C.

Guéchot J, Trocmé C, Renversez JC, Sturm N, Zarski JP; ANRS HC EP 23 Fibrostar Study Group.

Clin Chem Lab Med. 2012 Jan 13;50(4):693-9. doi: 10.1515/cclm-2011-0858.

PMID:
22505560
[PubMed - indexed for MEDLINE]
17.

Phase II study of sirolimus in treatment-naive patients with advanced hepatocellular carcinoma.

Decaens T, Luciani A, Itti E, Hulin A, Roudot-Thoraval F, Laurent A, Zafrani ES, Mallat A, Duvoux C.

Dig Liver Dis. 2012 Jul;44(7):610-6. doi: 10.1016/j.dld.2012.02.005. Epub 2012 Mar 27.

PMID:
22459565
[PubMed - indexed for MEDLINE]
18.

Liver precursor cells increase hepatic fibrosis induced by chronic carbon tetrachloride intoxication in rats.

Chobert MN, Couchie D, Fourcot A, Zafrani ES, Laperche Y, Mavier P, Brouillet A.

Lab Invest. 2012 Jan;92(1):135-50. doi: 10.1038/labinvest.2011.143. Epub 2011 Sep 26.

PMID:
21946857
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive.

Boursier J, de Ledinghen V, Zarski JP, Fouchard-Hubert I, Gallois Y, Oberti F, Calès P; multicentric groups from SNIFF 32, VINDIAG 7, and ANRS/HC/EP23 FIBROSTAR studies.

Hepatology. 2012 Jan;55(1):58-67. doi: 10.1002/hep.24654.

PMID:
21898504
[PubMed - indexed for MEDLINE]
20.

Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial.

Benamouzig R, Uzzan B, Deyra J, Martin A, Girard B, Little J, Chaussade S; Association pour la Prévention par l'Aspirine du Cancer Colorectal Study Group (APACC).

Gut. 2012 Feb;61(2):255-61. doi: 10.1136/gutjnl-2011-300113. Epub 2011 Sep 2. Erratum in: Gut. 2012 Mar;61(3):472.

PMID:
21890814
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk